Posts from the Newsroom

Rallybio Expands Drug Acquisition and Development Capabilities

Rallybio Expands Drug Acquisition and Development Capabilities with Addition of Veteran Industry Executives Zubin Bhagwagar, MD, PhD and Haren Vasavada, PhD, join Rallybio to identify and advance early-stage assets into clinical development   FARMINGTON, CT, July 10,...

read more

BIO 2018

The Rallybio team is excited about the BIO International Convention that kicks off on Monday in Boston.  Over 17,000 biotech colleagues from 74 countries will converge on the Boston Convention & Exhibition Center and the Rallybio team has a full schedule of dozens of...

read more
Rallybio Completes $37.0M Series A Financing

Rallybio Completes $37.0M Series A Financing

Rallybio Established by Industry Leaders with $37.0 Million in Series A Financing to Develop Transformative Therapies for Patients with Severe and Rare Diseases FARMINGTON, CT, April 25, 2018 – Rallybio, LLC, a biotechnology company established to identify and...

read more
Connecticut Bioscience Advocacy 2018

Connecticut Bioscience Advocacy 2018

Rallybio will be attending Connecticut Bioscience Advocacy 2018 on Thursday, March 15th, at the Capitol in Hartford.  The conference is being hosted by BioCT and will focus on the importance of bioscience to our state’s economy and future biosciences crossroads. For...

read more